Ischemia and No Obstructive Coronary Artery Disease (INOCA)
Author(s) -
C. Noel Bairey Merz,
Carl J. Pepine,
Mary Norine Walsh,
Jerome L. Fleg,
Paolo G. Camici,
William M. Chilian,
Janine A. Clayton,
Lawton S. Cooper,
Filippo Crea,
Marcelo F. Di Carli,
Pamela S. Douglas,
Zorina S. Galis,
Paul A. Gurbel,
Eileen Handberg,
Ahmed Hasan,
Joseph A. Hill,
Judith S. Hochman,
Erin Iturriaga,
Ruth Kirby,
Glenn N. Levine,
Peter Libby,
João L. M. P. de Lima,
Puja K. Mehta,
Patrice DesvigneNickens,
Michelle Olive,
Gail D. Pearson,
Arshed A. Quyyumi,
Harmony R. Reynolds,
British Robinson,
George Sopko,
Viviany R. Taqueti,
Janet Wei,
Nanette K. Wenger
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.024534
Subject(s) - medicine , cardiology , coronary artery disease , heart failure , coronary arteries , ejection fraction , acute coronary syndrome , stroke (engine) , intensive care medicine , myocardial infarction , artery , mechanical engineering , engineering
The Cardiovascular Disease in Women Committee of the American College of Cardiology, in conjunction with interested parties (from the National Heart, Lung, and Blood Institute, American Heart Association, and European Society of Cardiology), convened a working group to develop a consensus on the syndrome of myocardial ischemia with no obstructive coronary arteries. In general, these patients have elevated risk for a cardiovascular event (including acute coronary syndrome, heart failure hospitalization, stroke, and repeat cardiovascular procedures) compared with reference subjects and appear to be at higher risk for development of heart failure with preserved ejection fraction. A subgroup of these patients also has coronary microvascular dysfunction and evidence of inflammation. This document provides a summary of findings and recommendations for the development of an integrated approach for identifying and managing patients with ischemia with no obstructive coronary arteries and outlines knowledge gaps in the area. Working group members critically reviewed available literature and current practices for risk assessment and state-of-the-science techniques in multiple areas, with a focus on next steps needed to develop evidence-based therapies. This report presents highlights of this working group review and a summary of suggested research directions to advance this field in the next decade.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom